More on Cleveland BioLabs Q2 results

• Cleveland BioLabs (CBLI -9.9%) Q2 results: Revenues: $561.1K (-65.2%); Operating Expenses: $4.6M (-45.5%); Operating Loss: ($4.0M) (+40.8%); Net Loss: ($4.1M) (-6.3%); Loss Per Share: ($0.08) (-14.3%); Quick Assets: $11.1M (+11.0%): Cash Burn (1H): ($7.7M) (+45.4%).
• No guidance given.